147 related articles for article (PubMed ID: 9603949)
1. Coagulation factor XIIIa undergoes a conformational change evoked by glutamine substrate. Studies on kinetics of inhibition and binding of XIIIA by a cross-reacting antifibrinogen antibody.
Mitkevich OV; Shainoff JR; DiBello PM; Yee VC; Teller DC; Smejkal GB; Bishop PD; Kolotushkina IS; Fickenscher K; Samokhin GP
J Biol Chem; 1998 Jun; 273(23):14387-91. PubMed ID: 9603949
[TBL] [Abstract][Full Text] [Related]
2. Contact with the N termini in the central E domain enhances the reactivities of the distal D domains of fibrin to factor XIIIa.
Samokhin GP; Lorand L
J Biol Chem; 1995 Sep; 270(37):21827-32. PubMed ID: 7665605
[TBL] [Abstract][Full Text] [Related]
3. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
Achyuthan KE; Dobson JV; Greenberg CS
Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
[TBL] [Abstract][Full Text] [Related]
4. Identification of factor XIIIA-reactive glutamine acceptor and lysine donor sites within fibronectin-binding protein (FnbA) from Staphylococcus aureus.
Anderson ET; Fletcher L; Severin A; Murphy E; Baker SM; Matsuka YV
Biochemistry; 2004 Sep; 43(37):11842-52. PubMed ID: 15362870
[TBL] [Abstract][Full Text] [Related]
5. Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites.
Achyuthan KE; Slaughter TF; Santiago MA; Enghild JJ; Greenberg CS
J Biol Chem; 1993 Oct; 268(28):21284-92. PubMed ID: 8104938
[TBL] [Abstract][Full Text] [Related]
6. Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase.
Parameswaran KN; Velasco PT; Wilson J; Lorand L
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8472-5. PubMed ID: 1978326
[TBL] [Abstract][Full Text] [Related]
7. Identification of the alpha chain lysine donor sites involved in factor XIIIa fibrin cross-linking.
Sobel JH; Gawinowicz MA
J Biol Chem; 1996 Aug; 271(32):19288-97. PubMed ID: 8702612
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus aureus fibronectin-binding protein serves as a substrate for coagulation factor XIIIa: evidence for factor XIIIa-catalyzed covalent cross-linking to fibronectin and fibrin.
Matsuka YV; Anderson ET; Milner-Fish T; Ooi P; Baker S
Biochemistry; 2003 Dec; 42(49):14643-52. PubMed ID: 14661977
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody directed to a fibrinogen A alpha #529-539 epitope inhibits alpha-chain crosslinking by transglutaminases.
Mitkevich OV; Sobel JH; Shainoff JR; Vlasik TN; Kalantarov GF; Trakht IN; Streltsova ZA; Samokhin GP
Blood Coagul Fibrinolysis; 1996 Jan; 7(1):85-92. PubMed ID: 8845468
[TBL] [Abstract][Full Text] [Related]
10. Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII).
Gorman JJ; Folk JE
J Biol Chem; 1980 Jan; 255(2):419-27. PubMed ID: 6101325
[TBL] [Abstract][Full Text] [Related]
11. Biotinylated peptides containing a factor XIIIa or a tissue transglutaminase-reactive glutaminyl residue that block protein cross-linking phenomena by becoming incorporated into amine donor sites.
Lorand L; Parameswaran KN; Velasco PT; Murthy SN
Bioconjug Chem; 1992; 3(1):37-41. PubMed ID: 1352131
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic and kinetic properties of blood coagulation factor XIIIa and guinea pig liver transglutaminase utilizing (6-[N-(4-aminobutyl)-N-ethylamino]-2,3-dihydrophthalazine-1,4-dione, as a novel, specific and sensitive chemiluminescent substrate.
Achyuthan KE
J Biolumin Chemilumin; 1998; 13(1):1-11. PubMed ID: 9608360
[TBL] [Abstract][Full Text] [Related]
13. Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen.
Matsuka YV; Medved LV; Migliorini MM; Ingham KC
Biochemistry; 1996 May; 35(18):5810-6. PubMed ID: 8639541
[TBL] [Abstract][Full Text] [Related]
14. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.
Fukue H; Anderson K; McPhedran P; Clyne L; McDonagh J
Blood; 1992 Jan; 79(1):65-74. PubMed ID: 1370210
[TBL] [Abstract][Full Text] [Related]
15. Comparative structural and functional features of the human fibrinogen alpha C domain and the isolated alpha C fragment. Characterization using monoclonal antibodies to defined COOH-terminal A alpha chain regions.
Rudchenko S; Trakht I; Sobel JH
J Biol Chem; 1996 Feb; 271(5):2523-30. PubMed ID: 8576216
[TBL] [Abstract][Full Text] [Related]
16. Alpha-Chain cross-linking in fibrin(ogen) Marburg.
Sobel JH; Trakht I; Wu HQ; Rudchenko S; Egbring R
Blood; 1995 Aug; 86(3):989-1000. PubMed ID: 7620190
[TBL] [Abstract][Full Text] [Related]
17. Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases. Evidence for transglutaminase-catalyzed cross-linking to fibrin.
Valnickova Z; Enghild JJ
J Biol Chem; 1998 Oct; 273(42):27220-4. PubMed ID: 9765243
[TBL] [Abstract][Full Text] [Related]
18. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa.
Schense JC; Hubbell JA
Bioconjug Chem; 1999; 10(1):75-81. PubMed ID: 9893967
[TBL] [Abstract][Full Text] [Related]
19. Tridegin, a new peptidic inhibitor of factor XIIIa, from the blood-sucking leech Haementeria ghilianii.
Finney S; Seale L; Sawyer RT; Wallis RB
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):797-805. PubMed ID: 9210403
[TBL] [Abstract][Full Text] [Related]
20. Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA.
Sugimura Y; Hosono M; Wada F; Yoshimura T; Maki M; Hitomi K
J Biol Chem; 2006 Jun; 281(26):17699-706. PubMed ID: 16636049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
